Testosterone and Metabolic Health for Men on GLP-1s | LuxeFit Wellness

Men starting GLP-1 therapy for weight or metabolic health often arrive at their clinician’s intake with a sensible question: could testosterone be part of the picture? Some notice fatigue, reduced libido, or slower-than-expected body-composition change. Others have read that weight-loss medications can alter hormone labs. The question is clinically reasonable because testosterone is increasingly understood as a metabolic hormone, not merely a reproductive one. Its biology intersects with the same pathways that GLP-1 receptor agonists influence, including insulin sensitivity, skeletal muscle protein balance, adipose signaling, and bone density.

This article explains what the peer-reviewed evidence says about testosterone’s metabolic role, how GLP-1-associated weight loss can change the way testosterone is measured and interpreted, and why any consideration of testosterone therapy should happen through structured, clinician-guided evaluation rather than online “optimization” promises.

Why Testosterone Is a Metabolic Hormone, Not Just a Sex Hormone

For decades, testosterone was framed almost exclusively around libido, fertility, and secondary sexual characteristics. More recent work positions it as a broadly metabolic signal. In their review, Kelly and Jones describe testosterone as a metabolic hormone in health and disease, emphasizing that androgen receptor signaling is present in adipose tissue, skeletal muscle, liver, and vascular endothelium [PMID 23378050](https://pubmed.ncbi.nlm.nih.gov/23378050). Mauvais-Jarvis and colleagues, in a 2026 framing of testosterone as a metabolic messenger, further trace how androgens regulate energy substrate partitioning, mitochondrial function, and adipose tissue remodeling [PMID 41514077](https://pubmed.ncbi.nlm.nih.gov/41514077).

Low testosterone concentrations in men are associated with higher visceral adiposity, dyslipidemia, and insulin resistance. These associations do not prove that raising testosterone will reverse metabolic disease, but they do explain why men with untreated hypogonadism often present with overlapping metabolic concerns. The key clinical point is that testosterone status deserves attention whenever a patient is being treated for metabolic or weight-related disease, because the conditions can influence one another.

What Changes During GLP-1 Therapy That Can Affect Testosterone Readings

GLP-1 receptor agonists produce weight loss and improve glycemic control through appetite, gastric emptying, and insulin-glucagon effects. Those metabolic improvements, in turn, can shift the proteins that carry testosterone in circulation.

Testosterone travels mostly bound to sex hormone-binding globulin (SHBG) and albumin, with only a small unbound fraction considered biologically active. Goldman and colleagues review how changes in binding-protein concentrations alter the measured total testosterone level without necessarily changing the free, physiologically active hormone [PMID 28673039](https://pubmed.ncbi.nlm.nih.gov/28673039). When a man loses substantial fat mass on a GLP-1, SHBG often rises; because insulin normally suppresses SHBG production, lower insulin exposure can further increase SHBG. The result is a total testosterone number that may look higher even though the free testosterone level, and the patient’s symptomatic picture, may not have changed proportionally.

This is one of the more common sources of confusion in post-GLP-1 labs. A clinician interpreting a single total testosterone value without considering SHBG, albumin, and symptoms can either overdiagnose improvement or miss ongoing functional deficiency. Repeat morning testing and measurement of free or bioavailable testosterone become important when weight and metabolic status have shifted.

Muscle, Bone, and Functional Health During Weight Loss

Rapid or significant weight loss can reduce lean mass along with fat mass. Preserving skeletal muscle matters for metabolic rate, glucose disposal, physical function, and long-term weight maintenance. Testosterone is a key anabolic signal for muscle protein synthesis and for the maintenance of bone mineral density.

Bhasin and colleagues summarize the mechanisms of testosterone’s anabolic effects on muscle and function, including its roles in myogenic differentiation, muscle protein balance, and neuromuscular performance, while also noting areas of ongoing scientific debate [PMID 41355050](https://pubmed.ncbi.nlm.nih.gov/41355050). Separately, Tenuta and coauthors describe testosterone as one piece of the broader puzzle of male bone health, interacting with vitamin D, IGF-1, mechanical loading, and estrogen conversion [PMID 40120082](https://pubmed.ncbi.nlm.nih.gov/40120082).

For men on GLP-1s, the clinical implication is practical: if weight loss uncovers or worsens low testosterone, the combined effect may accelerate sarcopenia or bone turnover in those already at risk. Conversely, replacing testosterone in a man who is not deficient does not reliably produce additional muscle gain and is not an approved strategy for body recomposition.

Mood, Energy, and Quality of Life

Testosterone deficiency is associated with reduced energy, irritability, depressed mood, and diminished quality of life, though these symptoms are nonspecific. Zitzmann’s review of testosterone, mood, behaviour, and quality of life underscores that the relationship is bidirectional and modulated by age, sleep, thyroid function, and psychosocial factors [PMID 32657051](https://pubmed.ncbi.nlm.nih.gov/32657051).

Men on GLP-1s may interpret fatigue or low motivation as a medication side effect, a calorie-deficit effect, or a sign that testosterone is low. A careful history and repeat morning labs are required before attributing these symptoms to testosterone deficiency. GLP-1s can also cause gastrointestinal symptoms, dehydration, or sleep disruption, all of which can mimic hormonal complaints.

How to Read Your Labs: Total Testosterone, Free Testosterone, and SHBG

A high-quality testosterone workup typically starts with a morning total testosterone level, because testosterone follows a circadian rhythm. If the initial value is low or borderline, it should be repeated on a separate morning. When SHBG is likely altered, by weight loss, metabolic disease, or medications, free testosterone should be measured or calculated.

Goldman et al. review the physiological and clinical implications of testosterone binding, making clear that total testosterone alone can be misleading when binding-protein concentrations change [PMID 28673039](https://pubmed.ncbi.nlm.nih.gov/28673039). For men on GLP-1s, this is directly relevant: a post-treatment total testosterone value that has “normalized” may still mask low bioavailable testosterone, or a low total value may be artifactually driven by high SHBG rather than by reduced testicular production.

Is Testosterone Therapy Appropriate for Men on GLP-1s?

Testosterone replacement is indicated for men with consistent symptoms of testosterone deficiency and repeatedly low morning testosterone levels, evaluated against current endocrine criteria. It is FDA-approved for male hypogonadism; it is not approved for weight loss, metabolic augmentation, or performance enhancement.

If a man on a GLP-1 is found to have true hypogonadism, testosterone therapy may be a reasonable part of a broader metabolic plan. Monitoring should include hematocrit, prostate-specific antigen and digital examination as clinically indicated, and follow-up symptom and laboratory assessment. Testosterone therapy can suppress spermatogenesis, so fertility goals must be discussed before starting.

The decision should never be made on a single lab value or a symptom checklist alone. Shared decision-making between patient and clinician is essential, especially when two pharmacologic interventions are influencing overlapping metabolic systems.

Practical Questions to Ask Your Clinician

Use your LuxeFit consultation to move beyond marketing language and into measurable clinical reasoning. Questions worth asking include:

• Should my testosterone be checked before and after starting a GLP-1, and what panel is most informative?
• If my total testosterone rises during weight loss, does that mean my free testosterone has improved too?
• What symptoms should prompt a re-check, and how do we separate them from GLP-1 side effects?
• If I start testosterone, how often will we monitor hematocrit, PSA, and lipid or glucose markers?
• Are there lifestyle or sleep interventions we should optimize before adding testosterone?

If a provider cannot explain the difference between total and free testosterone, or treats testosterone as a blanket add-on to every weight-loss protocol, that is a signal to seek a more rigorous evaluation.

FAQ

Can GLP-1 therapy raise testosterone levels? Weight loss and improved metabolic health can raise SHBG, which often increases measured total testosterone. Whether free, bioavailable testosterone improves varies by individual and should be confirmed with repeat morning labs.

Will testosterone help me lose more weight on a GLP-1? Testosterone is not approved for weight loss. In men with documented hypogonadism, replacement may improve energy, body composition, and metabolic parameters, but it is not a substitute for GLP-1 therapy or lifestyle change.

Is testosterone safe to use with GLP-1 medications? Both can be used together when clinically appropriate, but only under clinician supervision. Monitoring for hematocrit, prostate health, fertility, and metabolic markers is necessary.

How is low testosterone diagnosed? It requires consistent symptoms plus repeatedly low morning total testosterone, often with confirmation of free or bioavailable testosterone. A single borderline result is not sufficient.

Should every man on a GLP-1 get testosterone testing? Not automatically. Testing is reasonable when symptoms suggest deficiency, when weight loss has been rapid, or when baseline labs are unclear. The decision should be individualized.

Summary of Key Considerations

A Calm, Evidence-Based Path Forward

Testosterone and GLP-1 therapy sit at the same metabolic intersection: energy balance, body composition, insulin sensitivity, and long-term cardiometabolic risk. For men in the DFW area considering both, the safest path is a structured, cash-pay, virtual intake that treats testosterone status as part of a broader metabolic picture rather than a standalone prescription.

At LuxeFit Wellness, our clinician-guided process begins with baseline labs, symptom review, and a clear discussion of what the evidence supports and where the evidence is still evolving. If testosterone deficiency is confirmed, we design a monitoring plan that accounts for GLP-1-associated changes in weight, SHBG, and metabolic markers. If it is not confirmed, we focus on the lifestyle and hormonal foundations that are more likely to drive durable improvement.

Schedule a LuxeFit consult to review your labs, symptoms, and goals with a clinician who can separate hormone hype from hormone biology.

Educational Disclaimer

This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Care decisions, eligibility, dosing, contraindications, and monitoring for testosterone therapy or GLP-1 medications must be managed by a licensed healthcare professional. Never start, stop, or combine medications or peptide protocols without formal clinical oversight.

References

[Kelly DM et al. — Testosterone: a metabolic hormone in health and disease](https://pubmed.ncbi.nlm.nih.gov/23378050/) [Ide H — The impact of testosterone in men's health](https://pubmed.ncbi.nlm.nih.gov/37045775/) [Mauvais-Jarvis F et al. — Metabolic Messengers: testosterone](https://pubmed.ncbi.nlm.nih.gov/41514077/) [Tenuta M et al. — Testosterone and Male Bone Health: A Puzzle of Interactions](https://pubmed.ncbi.nlm.nih.gov/40120082/) [Zitzmann M — Testosterone, mood, behaviour and quality of life](https://pubmed.ncbi.nlm.nih.gov/32657051/) [Goldman AL et al. — A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications](https://pubmed.ncbi.nlm.nih.gov/28673039/) [Bhasin S et al. — Mechanisms of Testosterone's Anabolic Effects on Muscle and Function: Controversies and New Insights](https://pubmed.ncbi.nlm.nih.gov/41355050/)